Ivadantin

   
Google
 
Web NewDrugInformation.com

Ivadantin


Drug - Ivadantin
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Nitrofurantoin Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 180MG BASE/VIAL
The potency of the active ingredient(s), Nitrofurantoin Sodium. May repeat for multiple part products.

Applicant - PROCTER AND GAMBLE
The firm name holding legal responsibility for Ivadantin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 012402
The FDA assigned number to Ivadantin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ivadantin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Ivadantin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ivadantin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Ivadantin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co
The full name of the firm holding legal responsibility for the new application of Ivadantin.

Ivadantin